Nuvation Bio Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
NUVB, NUVB-WT on NYSE
Industry
Pharmaceutical Preparations
Location
357 Tehama Street, Floor 3, San Francisco, CA

Insiders trading volume in the past year

Nuvation Bio Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Omega Fund V, L.P. 10%+ Owner $115M Apr 5, 2022
David Hung PRESIDENT AND CEO, Director, 10%+ Owner $106M +$1.71M +1.64% Jun 16, 2025
Xiangmin Cui Director $77.1M Sep 3, 2024
Junyuan Jerry Wang CEO, ANHEART THERAPEUTICS LTD., Director $17.7M Nov 11, 2024
Oleg Nodelman Director $17.3M Sep 19, 2023
Daniel G. Welch Director $1.08M May 24, 2024
Dongfang Liu Chief Medical Officer $1.07M -$1.67M -60.9% Dec 1, 2025
Kim Blickenstaff Director $500K May 21, 2025
Robert Mashal Director $334K +$167K +100% Aug 11, 2025
David C. Hanley Chief Technical Operations $171K -$1.43M -89.3% Nov 19, 2025
Colleen Sjogren Chief Commercial Officer $146K +$90.4K +161% Jun 16, 2025
Kerry Wentworth Chief Regulatory Officer $90K +$89.7K +34515% Jun 16, 2025
Stacy Markel Chief People Officer $50.6K +$17.1K +51% Jun 18, 2025
Moses Makunje Title: VP, Finance and principal financial and accounting officer. $44.1K Feb 28, 2025
Philippe Sauvage Chief Financial Officer $17.7K +$13.2K +293% Jun 16, 2025
Jennifer Fox Chief Financial Officer $6.1K Feb 28, 2023
Gary Hattersley Chief Scientific Officer $0 -$3.17M -100% Nov 20, 2025
Robert B. Bazemore Director May 21, 2025
Vernon W Anthony Director May 21, 2025
Kathryn E. Falberg Director May 21, 2025

Recent Insider Transactions by Companies or Individuals for Nuvation Bio Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.